SCHEMBL2204286

SCHEMBL2204286

COc1ccc(CCNC(=O)c2ccc(C(=O)C(F)(F)F)s2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.78
HDAC4 P56524 5/20 0.78
HDAC6 Q9UBN7 5/20 0.78
HDAC3 O15379 4/20 0.78
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 1/20 0.52
ALDH1A1 P00352 1/20 0.52
RAB9A P51151 1/20 0.52
GLA P06280 2/20 0.50
CLK1 P49759 1/20 0.50
GAA P10253 1/20 0.50
LMNA P02545 1/20 0.50
NAMPT P43490 1/20 0.50
KDM4E B2RXH2 1/20 0.50
CASP1 P29466 1/20 0.50
HSD17B10 Q99714 1/20 0.50
KMT2A Q03164 1/20 0.49
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200725 0.88 HDAC1 (1.00) HDAC1HDAC4HDAC6HDAC3NPC1
SCHEMBL2203343 0.86 HDAC1 (0.80) HDAC1HDAC4HDAC6HDAC3SMN1; SMN2
SCHEMBL4767602 0.85 HDAC1 (0.78) HDAC1HDAC4HDAC6HDAC3SMN1; SMN2
SCHEMBL4774806 0.83 HDAC1 (1.00) HDAC1HDAC4HDAC6HDAC3SMN1; SMN2
SCHEMBL2201378 0.80 HDAC1 (0.68) HDAC1HDAC4HDAC6HDAC3SMN1; SMN2
SCHEMBL2228785 0.80 HDAC1 (0.73) HDAC1HDAC4HDAC6HDAC3SMN1; SMN2
SCHEMBL140038 0.77 SMN1; SMN2 (0.67) SMN1; SMN2ALDH1A1GLAKMT2A
SCHEMBL2201189 0.76 HDAC1 (0.71) HDAC1HDAC4HDAC6HDAC3ALDH1A1
SCHEMBL2229969 0.76 HDAC6 (0.74) HDAC1HDAC4HDAC6HDAC3SMN1; SMN2
SCHEMBL4929057 0.75 ACKR3 (0.57) HDAC1HDAC4HDAC6HDAC3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP claimed
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 HDAC1 1/4885HDAC4 4/4885HDAC6 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.